Tumor Nutrition

Tumor Nutrition Market Outlook

The global Tumor Nutrition Market is expected to reach a valuation of approximately USD 9.6 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.2% between 2025 and 2035. The rising prevalence of cancer, alongside a growing awareness of the importance of nutritional support during cancer treatment, is driving this market forward. Additionally, the increasing adoption of enteral and parenteral nutrition among healthcare providers is contributing significantly to the market growth. The shift towards personalized nutrition based on the specific needs of cancer patients and advancements in nutritional formulations are expected to further bolster market expansion. Furthermore, the rising focus on improving the quality of life of patients undergoing treatment has led to a clearer understanding of nutrition's role, thus fostering market development.

Growth Factor of the Market

The Tumor Nutrition Market is significantly influenced by various growth factors that ensure its continuous expansion. One of the primary drivers is the increasing incidence of cancer globally, with millions diagnosed each year necessitating effective nutritional support. Research shows that proper nutrition can significantly enhance the effectiveness of cancer treatments and improve recovery outcomes. Additionally, the aging population is more susceptible to cancer, further amplifying the need for specialized nutritional products. Healthcare professionals are increasingly recognizing the role of nutritional management in cancer care, leading to a growing demand for tailored nutritional solutions. Furthermore, advancements in nutritional science and product formulations have resulted in more effective and appealing products for patients, thus contributing to market growth.

Key Highlights of the Market

• Growing awareness regarding the importance of nutrition in cancer care.
• Rising incidence of cancer globally, leading to increased demand for tumor nutrition products.
• Advancements in nutritional formulations and delivery systems.
• Shift towards personalized nutrition plans based on individual patient needs.
• Increased investments in research and development for innovative nutritional solutions.

By Product Type

Liquid Nutritional Supplements:

Liquid nutritional supplements are a vital component of the Tumor Nutrition Market, specifically designed to provide essential nutrients in an easily digestible format. These supplements are particularly beneficial for patients who have difficulty swallowing or those experiencing gastrointestinal issues related to their treatment. Liquid formulas often combine proteins, carbohydrates, fats, vitamins, and minerals to ensure a balanced intake of nutrients. Their convenience and variety make them an attractive option for cancer patients, enabling better adherence to dietary recommendations. Due to their effectiveness in managing malnutrition and aiding recovery, the demand for liquid nutritional supplements continues to rise significantly within the market.

Enteral Nutrition:

Enteral nutrition involves delivering nutrients directly into the gastrointestinal tract, often through a feeding tube. This method is essential for patients who cannot consume food orally due to various reasons, such as surgery, medication side effects, or swallowing difficulties. Enteral nutrition is designed to provide all the essential nutrients required for recovery and maintenance of health, particularly in oncology settings. The growing preference for enteral nutrition among healthcare professionals, attributed to its ability to optimize nutritional status without invasive procedures, has positively impacted its market segment. Moreover, advancements in enteral formulas have improved the taste and tolerance, further enhancing patient compliance.

Parenteral Nutrition:

Parenteral nutrition involves the intravenous delivery of nutrients, bypassing the digestive system entirely. This form of nutrition is crucial for cancer patients who may have severe gastrointestinal complications or are unable to absorb nutrients effectively. Parenteral nutrition provides a complete profile of essential nutrients, including proteins, carbohydrates, fats, vitamins, and trace elements, ensuring that patients receive the necessary care during their treatment. The substantial demand for parenteral nutrition, driven by the increasing need for nutritional support in complex medical cases, continues to shape its segment's growth within the tumor nutrition market. Ongoing advancements in parenteral formulations and delivery methods are anticipated to enhance patient outcomes and compliance.

Protein Supplements:

Protein supplements play a pivotal role in the Tumor Nutrition Market, as adequate protein intake is critical for cancer patients to maintain muscle mass and overall health. These supplements are available in various forms, including powders, bars, and ready-to-drink shakes, catering to the diverse preferences of patients. Protein supplementation is essential for supporting recovery, enhancing immune function, and minimizing the adverse effects of cancer treatments. The growing recognition of the need for high-protein diets among patients undergoing treatments is driving the segment's growth. Furthermore, the availability of specialized protein formulations tailored for oncology patients is expected to enhance the market's expansion.

Carbohydrate Supplements:

Carbohydrate supplements are designed to provide patients with essential energy sources crucial during treatment. These supplements come in various forms, including powders, gels, and bars, which can be easily consumed by patients facing appetite loss or dietary restrictions. Adequate carbohydrate intake is vital for ensuring that cancer patients maintain their energy levels and support their overall health. The rising awareness of the role of carbohydrates in nutrition, coupled with a growing demand for convenient and easy-to-digest options, contributes to the increasing popularity of carbohydrate supplements within the tumor nutrition market. Additionally, innovations in carbohydrate formulations are expected to offer improved taste and digestibility, further driving market growth.

By Application

Cancer Cachexia:

Cancer cachexia is a complex metabolic syndrome associated with cancer, leading to severe weight loss, muscle wasting, and overall deterioration of health. Nutritional support for patients experiencing cachexia is critical for managing symptoms and improving quality of life. Specialized nutritional formulations designed for cachexia focus on providing concentrated sources of calories and proteins to help combat the condition. The increasing recognition of cancer cachexia as a significant aspect of oncology care is driving the demand for dedicated nutritional interventions. Furthermore, research efforts directed at understanding the mechanisms of cachexia are shaping the development of innovative products tailored specifically to address this challenging issue.

Malnutrition in Cancer Patients:

Malnutrition is a common issue faced by cancer patients, often exacerbated by treatment-related side effects such as nausea, vomiting, and loss of appetite. Addressing malnutrition through targeted nutritional support is crucial for enhancing treatment outcomes and improving overall well-being. Products designed to combat malnutrition are formulated to meet the specific needs of cancer patients, providing essential nutrients in concentrated and easily digestible forms. The increasing awareness of the impact of malnutrition on treatment efficacy and patient outcomes is fueling the demand for specialized nutritional interventions. As healthcare professionals prioritize the nutritional management of cancer patients, this segment is anticipated to witness substantial growth.

Post-Surgery Recovery:

Post-surgery recovery is a critical phase for cancer patients, during which proper nutrition plays a pivotal role in healing and regaining strength. Nutritional support during this phase focuses on providing the necessary nutrients to aid recovery, reduce complications, and foster optimal healing. Customized nutritional products that cater to the unique needs of post-surgical patients are gaining traction within the market. These products aim to enhance the patient's immune response and minimize the risk of infections and other complications. With the increasing emphasis on comprehensive care strategies, the demand for nutritional solutions tailored for post-surgery recovery is expected to grow significantly.

Palliative Care:

Palliative care is focused on improving the quality of life for patients with life-limiting illnesses, including cancer. Nutritional support plays a crucial role in this context, aiming to alleviate symptoms, enhance comfort, and maintain dignity. Products designed for palliative care are formulated to cater to the unique needs and preferences of patients, ensuring they receive essential nutrients in a palatable and easy-to-consume format. As the trend towards holistic patient-centered care gains momentum, the demand for specialized nutritional solutions within the palliative care segment is likely to witness considerable growth. This growth is fueled by increasing awareness of the importance of maintaining nutritional status in end-of-life care.

By Distribution Channel

Hospitals:

Hospitals are a primary distribution channel for tumor nutrition products, as they play a crucial role in the overall management of cancer patients. Nutritional support is often provided as part of comprehensive treatment plans, with healthcare professionals recommending specific products based on individual patient needs. Hospitals invest in specialized nutritional formulations designed to address the diverse challenges faced by cancer patients. The increasing focus on enhancing patient outcomes and reducing complications through nutritional management is driving the demand for tumor nutrition products in hospital settings. As a result, hospitals remain a dominant distribution channel with significant market impact.

Cancer Centers:

Cancer centers are specialized facilities dedicated to the treatment and care of cancer patients, making them a significant distribution channel for tumor nutrition products. Within these centers, nutritionists and oncologists collaborate to develop personalized nutritional plans tailored to each patient's unique requirements. The specialized focus on oncology ensures that cancer centers are equipped with a range of targeted nutritional products, facilitating optimal patient care. The increasing emphasis on the role of nutrition in cancer treatment is driving growth in this segment, with cancer centers actively promoting the use of nutritional support to enhance treatment efficacy and patient well-being.

Retail Pharmacies:

Retail pharmacies are emerging as an essential distribution channel for tumor nutrition products, providing patients with convenient access to various nutritional supplements. As awareness of the importance of nutrition in cancer care grows, retail pharmacies are increasingly stocking specialized nutritional products designed for cancer patients. These pharmacies serve as accessible points for patients to obtain essential nutrition products, often guided by pharmacists who can provide recommendations based on individual needs. The growing consumer preference for over-the-counter nutritional solutions and increased healthcare professional endorsements are propelling the expansion of this segment within the tumor nutrition market.

Online Pharmacies:

Online pharmacies are revolutionizing the way cancer patients access tumor nutrition products, providing a convenient and discreet purchasing experience. The rise of e-commerce in the healthcare sector has led to a significant increase in the availability of specialized nutritional products online. Patients can easily browse a wide range of options, read reviews, and select formulations that best suit their needs. The convenience of home delivery and access to a broader selection of products also contributes to the growing popularity of online pharmacies. As the demand for personalized nutrition solutions continues to rise, online pharmacies are expected to play an increasingly prominent role within the tumor nutrition market.

By Ingredient Type

Protein-based:

Protein-based products are a cornerstone of the Tumor Nutrition Market, as protein is essential for maintaining muscle mass and supporting overall health during cancer treatment. These products are formulated to provide concentrated protein sources in various forms, including powders, shakes, and bars. They are specifically designed to meet the heightened protein requirements of cancer patients, particularly those undergoing chemotherapy or experiencing weight loss. The growing recognition of the importance of protein in enhancing recovery and immune function is driving the demand for these products. As healthcare professionals increasingly advocate for high-protein diets in oncology care, the protein-based segment is expected to witness substantial growth.

Carbohydrate-based:

Carbohydrate-based products play a crucial role in providing energy for cancer patients, ensuring they can maintain their strength and vitality during treatment. These products are formulated to deliver easily digestible carbohydrates, helping to combat fatigue and support recovery. The increasing awareness of the importance of carbohydrate intake in maintaining nutritional balance is driving demand for these solutions. Innovations in carbohydrate formulations are also enhancing the taste and digestibility of these products, improving patient compliance. The growing focus on energy management in cancer care is expected to further propel the carbohydrate-based segment's growth in the tumor nutrition market.

Fat-based:

Fat-based products are an essential aspect of the Tumor Nutrition Market, providing a concentrated source of calories and essential fatty acids required for patients undergoing treatment. These products are formulated to deliver healthy fats in a palatable form, ensuring that patients receive adequate nutrition despite potential appetite loss. The increasing recognition of the role of fats in supporting overall health, particularly in cancer care, is driving the demand for fat-based nutritional solutions. Furthermore, the trend toward high-calorie diets tailored for cancer patients is expected to enhance the growth of this segment. As healthcare professionals emphasize the importance of balanced nutrition, fat-based products will play a crucial role in meeting these needs.

Vitamins and Minerals:

Vitamins and minerals are vital components of tumor nutrition products, ensuring that patients receive essential micronutrients necessary for overall health and well-being. These formulations aim to address potential deficiencies that may arise during cancer treatment, as patients often experience alterations in appetite and absorption. The growing awareness of the significance of micronutrient supplementation in supporting immune function and reducing treatment side effects is driving the demand for vitamin and mineral-rich products. Healthcare professionals increasingly advocate for comprehensive nutritional strategies that incorporate vitamins and minerals, thus enhancing patient care. This segment is poised for growth as more individuals recognize the importance of micronutrients in cancer management.

By Region

The North American region represents a significant share of the Tumor Nutrition Market, accounting for approximately 40% of the global market due to its advanced healthcare infrastructure and increasing focus on nutritional interventions in cancer care. The region is witnessing a growing prevalence of cancer, prompting healthcare providers to emphasize the importance of nutritional support for improving patient outcomes. The increasing adoption of enteral and parenteral nutrition, along with a rising number of cancer treatment facilities, further drives market growth in North America. Moreover, the region's investment in research and development for innovative nutritional solutions is expected to enhance the growth of this segment, with a projected CAGR of 6.0% by 2035.

Europe is another key region contributing significantly to the Tumor Nutrition Market, holding approximately 30% of the global market share. The increasing incidence of cancer across European countries is driving the demand for specialized nutritional products tailored for oncology patients. Several initiatives aimed at promoting awareness regarding the importance of nutrition in cancer care are further fuelling market growth in the region. Additionally, advancements in clinical nutrition and the availability of a wide range of tumor nutrition products through various distribution channels are anticipated to bolster the segment's expansion. As healthcare providers increasingly focus on patient-centered care, the European Tumor Nutrition Market is expected to witness robust growth in the coming years.

Opportunities

The Tumor Nutrition Market is poised to benefit from several emerging opportunities that could significantly enhance its growth trajectory. One prime opportunity lies in the increasing emphasis on personalized nutrition. As research continues to uncover the unique dietary needs of cancer patients based on their specific treatments and conditions, the development of customized nutritional solutions tailored to individual requirements is expected to gain traction. Companies that invest in research and development to create personalized formulations can position themselves at the forefront of this evolving market. Additionally, partnerships between nutritional companies, healthcare providers, and research institutions can foster the development of innovative products, thus creating collaborative opportunities for growth.

Another notable opportunity in the Tumor Nutrition Market is the rising trend of home healthcare and telemedicine. With an increasing number of patients opting for at-home treatment and nutritional support, companies can capitalize on this shift by offering convenient online purchasing options and home delivery services for nutritional products. The integration of telehealth services with nutritional counseling allows healthcare professionals to provide personalized advice and support to patients from the comfort of their homes. Furthermore, the ability to access reputable nutritional products through online platforms can enhance patient compliance and satisfaction, creating a favorable environment for market expansion in this segment.

Threats

Despite its growth potential, the Tumor Nutrition Market faces several threats that may hinder its progress. One of the significant challenges is the rising competition among existing players and new entrants. As the market attracts increased attention, the influx of competitors may lead to price wars and reduced profit margins for companies. Additionally, the presence of counterfeit or substandard products in the market poses a threat to patient safety and trust, potentially damaging the reputation of legitimate brands. Continuous innovation and the establishment of robust quality control measures will be essential for companies to navigate these challenges. The market must also adapt to changing consumer preferences and regulatory requirements to maintain its growth momentum.

Another concern affecting the Tumor Nutrition Market is the fluctuating availability of raw materials and supply chain disruptions. The market relies on specific ingredient sources for nutritional products, and any disruptions due to environmental factors, geopolitical issues, or trade restrictions can impact product availability and pricing. Companies must establish alternative sourcing strategies and maintain flexibility in their supply chains to mitigate these risks. Additionally, the ongoing battle against misinformation regarding nutrition and its role in cancer care can deter patients from utilizing specialized nutritional products. Therefore, educating healthcare professionals and patients about the importance of evidence-based nutritional support in cancer treatment is essential for overcoming this threat.

Competitor Outlook

• Nestlé Health Science
• Abbott Laboratories
• Danone S.A.
• Baxter International
• Cardinal Health
• Fresenius Kabi AG
• Mead Johnson Nutrition
• Performance Health
• Nutricia
• Ortho Clinical Diagnostics
• Hollister Incorporated
• Perrigo Company
• Sysco Corporation
• B. Braun Melsungen AG
• ProSpero Health

The competitive landscape of the Tumor Nutrition Market is characterized by a diverse range of players striving to establish their presence through innovative products and comprehensive service offerings. Leading companies such as Nestlé Health Science and Abbott Laboratories continue to dominate the market, leveraging their extensive research and development capabilities to create specialized nutritional formulations that cater to the unique needs of cancer patients. These companies are also actively engaged in partnerships and collaborations with healthcare institutions to enhance their product portfolios and increase market penetration. This competitive environment fosters continuous improvement and innovation, allowing companies to address the evolving challenges in cancer care effectively.

Another notable player in the Tumor Nutrition Market is Danone S.A., known for its nutritional expertise and commitment to enhancing patient outcomes through tailored nutritional solutions. The company's diverse range of products, including enteral and parenteral nutrition offerings, positions it favorably within the oncology nutrition space. Additionally, companies such as Fresenius Kabi AG and Baxter International are recognized for their comprehensive range of medical nutrition products, providing healthcare professionals with various options for patient support during cancer treatment. Their robust distribution networks and focus on quality assurance further contribute to their competitive advantage.

As the Tumor Nutrition Market continues to evolve, emerging players like ProSpero Health are making their mark by emphasizing personalized nutrition and innovative delivery methods. These companies are focused on conducting research to develop cutting-edge nutritional formulations that align with the latest scientific findings in oncology and nutrition. The emergence of online pharmacies and telehealth services is also reshaping the competitive landscape, allowing new entrants to tap into the growing demand for convenient access to specialized nutritional products. As the market grows, the competitive dynamics will continue to shift, with established players and newcomers alike striving to meet the nutritional needs of cancer patients effectively.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Nutricia
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Danone S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cardinal Health
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Perrigo Company
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 ProSpero Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sysco Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Performance Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Baxter International
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hollister Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Mead Johnson Nutrition
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Ortho Clinical Diagnostics
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Nestlé Health Science
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Tumor Nutrition Market, By Application
    • 6.1.1 Cancer Cachexia
    • 6.1.2 Malnutrition in Cancer Patients
    • 6.1.3 Post-Surgery Recovery
    • 6.1.4 Palliative Care
    • 6.1.5 Others
  • 6.2 Tumor Nutrition Market, By Product Type
    • 6.2.1 Liquid Nutritional Supplements
    • 6.2.2 Enteral Nutrition
    • 6.2.3 Parenteral Nutrition
    • 6.2.4 Protein Supplements
    • 6.2.5 Carbohydrate Supplements
  • 6.3 Tumor Nutrition Market, By Ingredient Type
    • 6.3.1 Protein-based
    • 6.3.2 Carbohydrate-based
    • 6.3.3 Fat-based
    • 6.3.4 Vitamins and Minerals
    • 6.3.5 Others
  • 6.4 Tumor Nutrition Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Cancer Centers
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Online Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Tumor Nutrition Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Tumor Nutrition market is categorized based on

By Product Type

• Liquid Nutritional Supplements
• Enteral Nutrition
• Parenteral Nutrition
• Protein Supplements
• Carbohydrate Supplements

By Application

• Cancer Cachexia
• Malnutrition in Cancer Patients
• Post-Surgery Recovery
• Palliative Care
• Others

By Distribution Channel

• Hospitals
• Cancer Centers
• Retail Pharmacies
• Online Pharmacies

By Ingredient Type

• Protein-based
• Carbohydrate-based
• Fat-based
• Vitamins and Minerals
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Nestlé Health Science
• Abbott Laboratories
• Danone S.A.
• Baxter International
• Cardinal Health
• Fresenius Kabi AG
• Mead Johnson Nutrition
• Performance Health
• Nutricia
• Ortho Clinical Diagnostics
• Hollister Incorporated
• Perrigo Company
• Sysco Corporation
• B. Braun Melsungen AG
• ProSpero Health